Author:
Casey B.,Pratt I.,Ryan M. P.
Publisher
Springer Berlin Heidelberg
Reference9 articles.
1. Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR (1982) Early clinical studies with cis-diamine-1,1,-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140–147
2. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cisplatin nephrotoxicity: II. Morphological observations. J Pharmacol Exp Ther 213(3):551–556
3. Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70–77
4. Harrap KR, Jones M, Wilkinson CR, Clink HMCD, Sparrow S, Mitchley BCV, Clarke S, Veasey A (1980) Antitumour, toxic and biochemical properties of cisplatin and eight other platinum complexes. In Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: current status and new developments. Academic, New York, pp 193–212
5. Jones BR, Bhalla RB, Mladek J, Kaleya RN, Gralla RJ, Alcock NW, Schwartz MK, Young CW, Reidenberg MM (1980) Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 27:557–562
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献